{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "15286778",
  "DateCompleted": {
    "Year": "2004",
    "Month": "10",
    "Day": "04"
  },
  "DateRevised": {
    "Year": "2009",
    "Month": "11",
    "Day": "19"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1078-8956",
      "JournalIssue": {
        "Volume": "10",
        "Issue": "8",
        "PubDate": {
          "Year": "2004",
          "Month": "Aug"
        }
      },
      "Title": "Nature medicine",
      "ISOAbbreviation": "Nat Med"
    },
    "ArticleTitle": "Treating cancer's kinase 'addiction'.",
    "Pagination": {
      "StartPage": "786",
      "EndPage": "787",
      "MedlinePgn": "786-7"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Baselga",
        "ForeName": "Jos\u00e9",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Arribas",
        "ForeName": "Joaqu\u00edn",
        "Initials": "J"
      }
    ],
    "PublicationTypeList": [
      "Historical Article",
      "News"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Nat Med",
    "NlmUniqueID": "9502015",
    "ISSNLinking": "1078-8956"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antineoplastic Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Piperazines"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Pyrimidines"
    },
    {
      "RegistryNumber": "EC 2.7.10.1",
      "NameOfSubstance": "Protein-Tyrosine Kinases"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antineoplastic Agents"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Drug Resistance, Neoplasm"
    },
    {
      "QualifierName": [
        "history"
      ],
      "DescriptorName": "Drug Therapy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "History, 20th Century"
    },
    {
      "QualifierName": [],
      "DescriptorName": "History, 21st Century"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug therapy",
        "genetics"
      ],
      "DescriptorName": "Leukemia, Myelogenous, Chronic, BCR-ABL Positive"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Mutation"
    },
    {
      "QualifierName": [
        "drug therapy",
        "genetics"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Piperazines"
    },
    {
      "QualifierName": [
        "antagonists & inhibitors"
      ],
      "DescriptorName": "Protein-Tyrosine Kinases"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Pyrimidines"
    }
  ]
}